Local Institution - 0126

Hangzhou, Zhejiang 310022

1 studies enrolling now · 2 studies all time

What they study most

Hepatocellular Carcinoma (HCC), Urinary Bladder Neoplasms

Studies at this site

• A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206) — Recruiting now
• A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder — Stopped early